Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has a five-year cancer survival rate of 87.5 percent for all cancer types, ahead of the national benchmark of 82.8 percent, according data from the National Cancer Institute. The center includes the Advancing Childhood Cancer Therapies Clinic for pediatric research and care for patients with relapsed, refractory or recurrent cancer. U.S. News & World Report ranked the center as the No. 2 pediatric cancer center in the country for 2017-18.
| ← Previous | RETURN TO FULL LIST | Next → |
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
